Vaccine Demand Boosts GlaxoSmithKline's Q2 Sales, Earnings; Maintains FY21 Guidance

  • GlaxoSmithKline Plc's GSK turnover was £8.1 billion in Q2, up 6% Y/Y (actual exchange rate AER), 15% (constant exchange rate CER).
  • Pharmaceuticals sales reached £4.2 billion, up 3% AER, 12% CER, driven by strong growth in New & Specialty products, favorable US RAR adjustments, and a prior year comparator impacted by destocking of COVID-19 related first quarter additional demand.
  • Vaccines sales grew 39% AER, 49% CER to £1.6 billion, primarily driven by pandemic adjuvant sales, higher demand for DTPa-containing vaccines in the US, and higher demand for Bexsero.
  • Vaccines turnover excluding pandemic vaccines grew 16% AER, 24% CER to £1.3 billion. 
  • Sales of its meningitis vaccine rose 46%, with shots for hepatitis and diphtheria up 28% as traditional hospital and doctor appointments rebounded from the COVID-19 disruption.
  • Adjusted operating margin of 26.7% was 3.7 percentage points higher at AER and 5.6 percentage points higher on a CER basis than in Q2 2020.
  • Adjusted EPS was 28.1p, up 46% AER, 71% CER.
  • The net cash inflow from operating activities was £1.3 billion. The free cash outflow was £316 million.
  • Outlook: GlaxoSmithKline reaffirmed 2021 adjusted EPS outlook to decline by mid-to-high single-digit percentage at CER.
  • As Shingrix sales are recovering more slowly in ex-US markets, the Company expects vaccines revenue for 2021 to be broadly flat.
  • Price Action: GSK shares are down 1.44% at $38.95 during the premarket session on the last check Wednesday.

Posted In: BriefsBiotechEarningsNewsGuidanceHealth CareGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.